newsfilter
← Latest News
Earnings Call Transcripts·

Roivant Sciences Ltd. (ROIV) Discusses On Brepocitinib In DM: VALOR Phase 3 Study Results Conference (Transcript)

Roivant Sciences Ltd. (ROIV) Discusses On Brepocitinib In DM: VALOR Phase 3 Study Results Conference (Transcript)